These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2486262)

  • 41. Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement.
    Shoemaker LR; Strife CF; Balistreri WF; Ryckman FC
    Pediatrics; 1992 Feb; 89(2):251-5. PubMed ID: 1734392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reciprocal auxiliary partial liver transplant for inborn noncirrhotic metabolic diseases.
    Read WL
    Transplantation; 2007 May; 83(10):1405-6. PubMed ID: 17519797
    [No Abstract]   [Full Text] [Related]  

  • 43. Blood group-specific antigens allow the elimination of recipient alloantibodies in paediatric ABO-incompatible liver transplantation.
    Yandza T; Lambert T; Gauthier F; De Dreuzy O; Lababidi A; Dubousset AM; De Victor D; Huault G; Valayer J
    Transplant Proc; 1994 Feb; 26(1):257-8. PubMed ID: 8108966
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusual indications for liver transplantation.
    Fagiuoli S; Caraceni P; Wright IH; Gavaler JS; Van Thiel DH
    Ital J Gastroenterol; 1994; 26(6):318-25. PubMed ID: 7949269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver transplantation is not curative for methylmalonic acidopathy caused by methylmalonyl-CoA mutase deficiency.
    Kaplan P; Ficicioglu C; Mazur AT; Palmieri MJ; Berry GT
    Mol Genet Metab; 2006 Aug; 88(4):322-6. PubMed ID: 16750411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Significance of alpha-1-antitrypsin deficiency in pediatric practice].
    Kapuscinska A
    Pol Tyg Lek; 1974 Mar; 29(9):373-6. PubMed ID: 4601489
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hepatic fibrosis by alpha-l-antitrypsin in a child: ultrastructural finding (author's transl)].
    Antoci B; Panizzo R
    Pathologica; 1979; 71(1012):201-10. PubMed ID: 314087
    [No Abstract]   [Full Text] [Related]  

  • 49. Orthotopic liver transplantation for adult-onset type II citrullinaemia.
    Kawamoto S; Strong RW; Kerlin P; Lynch SV; Steadman C; Kobayashi K; Nakagawa S; Matsunami H; Akatsu T; Saheki T
    Clin Transplant; 1997 Oct; 11(5 Pt 1):453-8. PubMed ID: 9361940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An ethical and policy analysis of elective transplantation for metabolic conditions diagnosed by newborn screening.
    Ross LF
    J Pediatr; 2010 Jan; 156(1):139-44. PubMed ID: 20006764
    [No Abstract]   [Full Text] [Related]  

  • 51. Liver transplantation for metabolic disorders.
    Cohen A; O'Grady J; Mowat A; Williams R
    Baillieres Clin Gastroenterol; 1989 Oct; 3(4):767-86. PubMed ID: 2701720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical and metabolic aspects of liver transplantation for tyrosinemia.
    Luks FI; St-Vil D; Hancock BJ; Laberge JM; Bensoussan AL; Russo P; Mitchell G; Lambert M; Blanchard H
    Transplantation; 1993 Dec; 56(6):1376-80. PubMed ID: 8279006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fetal liver cell transplantation: survival of grafted BALB/c lysosomal storage disease mice.
    Veyron P; Touraine JL
    Transplant Proc; 1990 Oct; 22(5):2253-4. PubMed ID: 2219360
    [No Abstract]   [Full Text] [Related]  

  • 54. Heterotopic liver transplantation corrects the inborn error of hepatic metabolism in a dog model.
    Madern GC; Terpstra OT; Sinaasappel M; Provoost AP; Rothuizen J; Molenaar JC
    Transplant Proc; 1991 Feb; 23(1 Pt 1):716-7. PubMed ID: 1990662
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatic imaging with computed tomography of chronic tyrosinaemia type 1.
    Macvicar D; Dicks-Mireaux C; Leonard JV; Wight DG
    Br J Radiol; 1990 Aug; 63(752):605-8. PubMed ID: 2400875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tyrosinosis. A difficult diagnosis of late infancy].
    Bertolani MF; Pellegrino AM; Summa C; Scalera E
    Minerva Pediatr; 1990; 42(1-2):1-7. PubMed ID: 2159592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paediatric liver transplantation for metabolic disorders. Part 1: Liver-based metabolic disorders without liver lesions.
    Darwish AA; McKiernan P; Chardot C
    Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):194-203. PubMed ID: 21376697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using human-induced pluripotent stem cells to model monogenic metabolic disorders of the liver.
    Ordonez MP; Goldstein LS
    Semin Liver Dis; 2012 Nov; 32(4):298-306. PubMed ID: 23397530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transplantation of the liver.
    Putnam CW; Starzl TE
    Surg Clin North Am; 1977 Apr; 57(2):361-73. PubMed ID: 322337
    [No Abstract]   [Full Text] [Related]  

  • 60. Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.
    van Spronsen FJ; Berger R; Smit GP; de Klerk JB; Duran M; Bijleveld CM; van Faassen H; Slooff MJ; Heymans HS
    J Inherit Metab Dis; 1989; 12 Suppl 2():339-42. PubMed ID: 2556611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.